“I let my obsession with being perfect ruin my life”: confessions of a recovering perfectionist
Written by Radhika Sanghani Radhika Sanghani was a lifelong perfectionist until the end of a relationship provided a much-needed wake-up
Read moreChina reports 6,074 new COVID cases on May 2, down from previous day
People wait for their orders outside a restaurant, after the government banned dine-in services, following the coronavirus disease (COVID-19) outbreak
Read moreWoman says Amazon.com fired her because she got 'long COVID' – lawsuit
NEW YORK (Reuters) – A former Amazon.com Inc employee sued the online retailer on Monday, saying it wrongly fired her
Read moreYou Can Now Pre-Order This Super Stealth, Kink-Inspired Sex Toy Jewelry on Kickstarter
If you purchase an independently reviewed product or service through a link on our website, SheKnows may receive an affiliate
Read moreTelehealth can play a vital role in reducing carbon emissions
Telehealth’s potential to bridge the services gap for people without ready transportation access has been well-documented. Less explored, however, is
Read moreNew research could help identify babies at risk of brain bleeds
WEHI researchers have uncovered a new way to help identify babies and fetuses at high-risk of developing brain bleeds, paving
Read moreImage-based mechanical simulations improve accuracy in gauging healing progress of bone fractures
When you first break a bone, the body sends out an inflammatory response, and cells begin to form a hematoma
Read moreWalmart launches telehealth program aimed at diabetes
Walmart Health’s telehealth company MeMD launched a virtual care diabetes program this past week aimed at helping individuals improve management
Read morePotent intracellular antiviral activity of human IgG3 depends on the hinge region
Humans have developed four different IgG antibody subclasses that orchestrate protection against invading pathogens. A molecular and cellular understanding of
Read moreUpadacitinib Earns FDA Approval for Ankylosing Spondylitis
The US Food and Drug Administration has approved upadacitinib (Rinvoq) as an oral treatment for active ankylosing spondylitis in adults,
Read more